BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma.

Dixon, Anthony J; Kyrgidis, Athanassios; Sladden, Michael; Nirenberg, Alexander; Steinman, Howard K; Smith, Harvey; Zachary, Christopher B; Anderson, Stuart; Leiter-Stöppke, Ulrike; Longo, Caterina; Apalla, Zoe.

Afiliação

Dixon AJ; Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia.
Kyrgidis A; Aristotle University of Thessaloniki, Thessaloniki, Greece.
Sladden M; University of Tasmania, Launceston, Tasmania, Australia.
Nirenberg A; Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia.
Steinman HK; Campbell University, Buies Creek, North Carolina, USA.
Smith H; Oxford Dermatology, Mt Hawthorn, Perth, Western Australia, Australia.
Zachary CB; Department of Dermatology, University of California Irvine, Irvine, California, USA.
Anderson S; Maffra Medical Group, Maffra, Victoria, Australia.
Leiter-Stöppke U; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
Longo C; Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.
Apalla Z; Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy.

J Eur Acad Dermatol Venereol ; 2024 Feb 20.

Article em En | MEDLINE | ID: mdl-38375764

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article